Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (631-640 of 643) with videos related to

Pageof 65
Sort By:
NAR Cancer|April 27, 2022
PDXNet portal: patient-derived Xenograft model, data, workflow and tool discoverySoner Koc, Michael W Lloyd, Jeffrey W Grover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket TrialPetros Grivas, Elena Garralda, Funda Meric-Bernstam, et al.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature|February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Cell|April 7, 2018
Pathogenic Germline Variants in 10,389 Adult CancersKuan-Lin Huang, R Jay Mashl, Yige Wu, et al.
Nature Medicine|January 19, 2023
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trialsTimothy A Yap, Naval Daver, Mikhila Mahendra, et al.
Cancer Discovery|December 7, 2019
Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i>-Mutant Metastatic Breast CancerLillian M Smyth, Sarina A Piha-Paul, Helen H Won, et al.
Nature Communications|August 25, 2021
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Cancer Research|July 31, 2024
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning AnalysisBrian S White, Xing Yi Woo, Soner Koc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor TypesPatrick G Pilié, Virginia Giuliani, Wei-Lien Wang, et al.
Pageof 65

Showing results (631-640 of 643) with videos related to

Sort By:
Pageof 65
NAR Cancer|April 27, 2022
PDXNet portal: patient-derived Xenograft model, data, workflow and tool discoverySoner Koc, Michael W Lloyd, Jeffrey W Grover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket TrialPetros Grivas, Elena Garralda, Funda Meric-Bernstam, et al.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature|February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Cell|April 7, 2018
Pathogenic Germline Variants in 10,389 Adult CancersKuan-Lin Huang, R Jay Mashl, Yige Wu, et al.
Nature Medicine|January 19, 2023
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trialsTimothy A Yap, Naval Daver, Mikhila Mahendra, et al.
Cancer Discovery|December 7, 2019
Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i>-Mutant Metastatic Breast CancerLillian M Smyth, Sarina A Piha-Paul, Helen H Won, et al.
Nature Communications|August 25, 2021
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Cancer Research|July 31, 2024
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning AnalysisBrian S White, Xing Yi Woo, Soner Koc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor TypesPatrick G Pilié, Virginia Giuliani, Wei-Lien Wang, et al.
Pageof 65